Background Canadians receive over 422 million prescriptions and spend over $26 billion
annually on drugs. Yet, we do not systematically capture information on whether the right …

Background Venous thromboembolism (VTE) is a major global cause of morbidity and
mortality. Low molecular weight heparin (LMWH) and fondaparinux (FDP) are frequently …

Background: Many medications pose greater health risks when prescribed for older adults,
compared with available pharmacologic and nonpharmacologic alternatives. We sought to …

Background: With the exception of Canada, all countries with universal health insurance
systems provide universal coverage of prescription drugs. Progress toward universal public …

Objectives To determine whether there is a relation between statin utilisation and coronary
heart disease (CHD) mortality in populations with different levels of coronary risk, and …

Health Care in Canada examines the challenges faced by the Canadian health care system,
a subject of much public debate. In this book Katherine Fierlbeck provides an in-depth …

Background: Some evidence supports the use of a short list of essential medicines to
improve prescribing. We aimed to create a preliminary essential medicines list for use in …

PURPOSE: To summarize observational studies that focus on the use of glaucoma
medications and to identify gaps in knowledge to guide future investigation. DESIGN …

Medications are the second largest and fastest growing health care cost in Canada. 1 In
2010, there were 499.6 million prescriptions dispensed across Canada, representing a total …

Objective Since January 2013, a nationwide drug utilization review (DUR) system for
therapeutic duplication (TD) of nonsteroidal antiinflammatory drugs (NSAIDs) has been …